Draft program WMA Leopoldina GMA DoH_231127

PDF Upload


The German Medical Association and the National Academy for Sciences Leopoldina
in collaboration with
the World Medical Association and the American Medical Association
and with kind support of
the State Chamber of Physicians of Bavaria
Research with vulnerable people:
A targeted interdisciplinary discussion
within the scope of the WMA Declaration of Helsinki revision
14-15 May 2024
State Chamber of Physicians of Bavaria, Munich, Germany
1
27 November 2023
Draft Program – Day 1 – 14 May
12 p.m. –
1:30 p.m.
Lunch for all participants
Chair: N.N.
2:00 –
2:30 pm
Welcome remarks
 Gerald Quitterer, MD, President, Bavarian State Chamber of Physicians
 Representative of the (Bavarian) government (tbc)
 Lujain AlQodmani, MD, WMA President
 Gerald Haug (ETHZ), President, Leopoldina
 Klaus Reinhardt, MD, President, German Medical Association
2:30 –
2:45 pm
Brief introduction and history of the WMA Declaration of Helsinki
 Ramin Parsa-Parsi, MD, MPH, Head of Department for International
Affairs, German Medical Association
2:45 –
3:00 pm
Introduction to the current DoH revision process and recap of previous WMA
conferences on vulnerable groups
 Jack Resneck, MD, Chair of WMA DoH Workgroup, AMA immediate past
president
3:00 –
3:15 pm
Introduction to the current discussion in the Leopoldina workgroup
 Urban Wiesing, MD, PhD, Chair of Leopoldina WG on vulnerable groups
3:15 –
3:45 pm
Mapping of vulnerability
 Pierre Mermet-Bouvier, Senior Manager, eCOA, ICON, France (tbc)
3:45 –
4:00 pm
Coffee break
4:00 –
5:00 pm
Analysis of vulnerability
 Samia Hurst, Director, Institute for Ethics, History, and the Humanities,
University of Geneva, Switzerland (tbc)
Vulnerability in different research settings
 Florencia Luna, Principal Researcher, FLACSO / CONICET, Argentina
Vulnerability as defined in the CIOMS guidelines
 Rieke van der Graaf, Julius Center, Department of Global Public Health &
Bioethics, UMC Utrecht, Netherlands
Food & Drug Administration (FDA), US (Speaker TBD)
5:00 –
5:45 pm
Panel discussion
Panel: Drs. Mermet, Hurst, Luna, van der Graf
Moderator: Steinunn Þórðardóttir, MD, Chair, WMA Medical Ethics Committee
6:00 p.m. Dinner
The German Medical Association and the National Academy for Sciences Leopoldina
in collaboration with
the World Medical Association and the American Medical Association
and with kind support of
the State Chamber of Physicians of Bavaria
Research with vulnerable people:
A targeted interdisciplinary discussion
within the scope of the WMA Declaration of Helsinki revision
14-15 May 2024
State Chamber of Physicians of Bavaria, Munich, Germany
2
27 November 2023
Draft Program – Day 2 – 15 May
Chair: N.N.
9:00 –
10:30 am
Delay of medicines, focus on children
 Gilles Vassal, Gustave Roussy Comprehensive Cancer Center, France
Children, subsidiarity of research
 Olaf Witt, University Hospital Heidelberg, Germany
Conditions under which research with vulnerable groups should be permitted.
 Alex John London, Director, Center for Ethics and Policy, Carnegie Mellon
University, US (tbc)
National Institutes of Health (NIH), US (Speaker TBD)
10:30 –
11:00 am
Coffee break
11:00 am –
12:30 am
Panel discussion and review of the WMA DoH paragraph on vulnerable groups
Panel: Drs. Vassal, Witt, London, Wiesing
Moderator: Jack Resneck, MD, Chair of WMA DoH workgroup
12:30 –
1:30 pm
Lunch for all participants
End of meeting
2:00 –
4:00 pm
Closed WMA DoH workgroup meeting
incl. selected guests
4:00 –
6:00 pm
Tour of Munich
(for all participants who registered for the tour)
6:00 pm Informal dinner
(for all participants who registered for the dinner)
in collaboration with
with kind support of